Survival Benefit Associated With Participation in Clinical Trials of Anticancer Drugs: A Systematic Review and Meta-analysis

R Iskander, H Moyer, K Vigneault, SM Mahmud… - JAMA, 2024 - jamanetwork.com
Importance Many cancer clinical investigators view clinical trials as offering better care for
patients than routine clinical care. However, definitive evidence of clinical benefit from trial …

Understanding the Hawthorne effect in wound research—a scoping review

VNB Nguyen, C Miller, J Sunderland… - International wound …, 2018 - Wiley Online Library
The Hawthorne Effect (HE) is considered a methodological artefact in research, although its
definition and influence on research outcomes lack consensus. This review explored how …

Impressions of early mobilization of critically ill children—clinician, patient, and family perspectives

K Zheng, A Sarti, S Boles, S Cameron… - Pediatric Critical Care …, 2018 - journals.lww.com
Objectives: To understand patient, family caregiver, and clinician impressions of early
mobilization, the perceived barriers and facilitators to its implementation, and the use of in …

Cancer patients' experiences with immune checkpoint modulators: a qualitative study

K Ala‐Leppilampi, NA Baker, C McKillop… - Cancer …, 2020 - Wiley Online Library
Background Minimal qualitative data exist on the experiences of cancer patients treated with
immune checkpoint inhibitors or costimulatory antibodies. Understanding the day to day …

Patient, Relative and Staff Experiences of Clinical Trial Participation in Neurooncology:“Maybe You Can Also Show the Positive, No Matter How It Ends”

R Thallner, C Gumbinger, A Hohmann… - Cancer Management …, 2024 - Taylor & Francis
Purpose There is a lack of evidence regarding how patients with malignant brain tumor and
their relatives experience participation in neurooncological clinical trials. Similarly, insights …

Dynamics and challenges of clinical trials in adolescents and young adults with cancer

LA Fern, A Bleyer - The Cancer Journal, 2018 - journals.lww.com
Inclusion in cancer clinical trials is considered the optimal standard of care, offering
improved patient experience and progressive survival gains for subsequent generations of …

TBCRC 057: Survey about willingness to participate in cancer clinical trials during the pandemic

KL Smith, C Mead‐Harvey, GL Mazza… - Cancer …, 2024 - Wiley Online Library
Background Breast cancer patients experienced heightened anxiety during the pandemic.
Also, modifications to clinical trial activities allowing for virtual platforms, local assessments …

Past-futures in experimental care: breast cancer and HIV medicine

S Day, W Viney, J Bruton, H Ward - New Genetics and Society, 2021 - Taylor & Francis
Cambrosio et al.(2018.“Extending Experimentation: Oncology's Fading Boundary Between
Research and Care.” New Genetics and Society 37 (3): 207–226) argue that “experimental …

Patient perspectives on compensation for biospecimen donation

SC Allen, M Lohani, KA Hendershot… - AJOB empirical …, 2018 - Taylor & Francis
Background: The purpose of this study was to determine whether biospecimen donors
believe they should receive compensation. This is the first study to report biospecimen …

Recruitment to the “Breast—Activity and Healthy Eating After Diagnosis”(B-AHEAD) Randomized Controlled Trial

M Pegington, JE Adams, NJ Bundred… - Integrative Cancer …, 2018 - journals.sagepub.com
Excess weight at breast cancer diagnosis and weight gain during treatment are linked to
increased breast cancer specific and all-cause mortality. The Breast—Activity and Healthy …